Eltrombopag for Treatment of Thrombocytopenia After Hematopoietic Stem Cell Transplantation.


Creative Commons License

Güven Z. T., Çelik S., Eser B., Çetin M., Ünal A., Kaynar L.

Turkish journal of haematology : official journal of Turkish Society of Haematology, cilt.39, ss.103-108, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

Özet

Objective: This study aimed to evaluate the efficacy and safety of eltrombopag (ELT) in the treatment of thrombocytopenia following hematopoietic stem cell transplantation (HSCT).